What should I look for in DSIP sourcing and quality?

Acceptable DSIP certificates of analysis specify: lot-specific (not template) issuance, HPLC purity ≥98%, mass spec confirmation matching 848 Da, endotoxin testing for injectable routes, and third-party accredited laboratory issuance. Template COAs, missing endotoxin data, or vendor-internal labs are red flags. Pharmaceutical-grade compounded material is the lowest-risk supply path where accessible.

What route should I use for DSIP?

DSIP is delivered by subq/intranasal. The intranasal route is preferred for compounds targeting the central nervous system because it bypasses the BBB via the olfactory pathway. The choice depends on target system and convenience.

What is the regulatory status of DSIP?

DSIP regulatory status: Unapproved in the United States; WADA status not on prohibited list; research level preclinical + small human series. Clinical access for off-label use is via compounded prescription where permissible. International regulatory status varies by jurisdiction. For male hormonal and performance use specifically, the regulatory profile shapes which monitoring and supervision approaches are required.

What is the evidence base for DSIP?

DSIP's evidence base sits at preclinical + small human series. The references on this page summarise 2 primary publications supporting the principal mechanism and applications. Where Phase II or Phase III human data exists for related indications, it is cited; where evidence is preclinical or limited to small case series, that is noted. The male physiology interpretation respects the actual evidence tier rather than over-stating mechanistic plausibility.

What does DSIP stack well with?

For male physiology protocols, DSIP pairs with compounds on complementary pathways: Kisspeptin, Gonadorelin (GnRH), PT-141. These pairings are selected because they engage independent receptor systems from DSIP's primary mechanism (Mechanism remains incompletely characterised), producing additive or synergistic effects rather than receptor competition.

What are the safety considerations for DSIP?

Excellent safety record across decades of research use. No reported serious adverse events. Avoid combining with strong CNS depressants. For male hormonal and performance use, additional considerations: baseline labs appropriate to the targeted system, mid-cycle re-check at 4–6 weeks, and end-of-cycle full re-evaluation. DSIP's ~7 min plasma; CNS effects longer pharmacokinetic profile and subq/intranasal administration route influence the side-effect profile in predictable ways.

Home/ Compounds/ DSIP

DSIP

Men's Health

Men's-health clinics treat DSIP as one component in a layered hormonal optimisation framework. A short neuropeptide isolated from sleeping rabbits in 1977, of interest for its modulation of delta-wave sleep and stress resilience. The relevant questions for male users are: does it interact with the HPG axis, is it compatible with current TRT or HCG protocols, and what are its effects on prostate, hematocrit, and cardiovascular indices over a ~7 min plasma; CNS effects longer-pharmacokinetics DSIP cycle? The sections below address each.

Male Physiology Applications

Sperm QualityErectile FunctionMuscle MassRecoveryStrength & Power

Key Takeaways

Male-physiology lens: DSIP is evaluated against HPG-axis interaction, TRT compatibility, and prostate / cardiovascular considerations.
Mechanism: Mechanism remains incompletely characterised.
Male monitoring: baseline testosterone (total/free), LH, FSH, estradiol, prolactin, SHBG; 6-8 week follow-up panel.
Male dose: 100-500 mcg 1x daily before sleep via subq/intranasal; cycle 8-12 weeks.
Male-physiology stack partners: Kisspeptin, Gonadorelin (GnRH), PT-141.

Male Physiology Mechanism

Mechanism remains incompletely characterised. Effects observed on delta-wave (slow-wave) sleep promotion, opioid receptor modulation indirectly via μ-receptor systems, and HPA axis dampening. Crosses the blood-brain barrier. For men, the downstream consequences of this mechanism are evaluated against four operational domains: HPG-axis interaction, recovery and body composition, sexual function and prostate, and integration with concurrent TRT or HCG protocols. DSIP's relationship to each is examined below.

Compatibility with TRT and post-cycle protocols

For men currently on TRT or planning a post-cycle restart, DSIP is typically compatible because it does not directly engage the HPG axis. The dominant interaction to watch for is on the metabolic and recovery layers rather than the hormonal layer. Where the molecule's pharmacology overlaps with HCG, gonadorelin, or kisspeptin, dose layering is the standard approach.

Sexual function and prostate considerations

Where DSIP alters circulating LH, testosterone, or local androgen signalling, prostate considerations become relevant for men over 40. Baseline PSA, periodic re-check, and avoidance of stacking that compounds androgenic load are all reasonable precautions. For molecules whose effects are predominantly outside the HPG axis, the prostate consideration is largely background.

Interaction with the HPG axis

DSIP's relationship to the male HPG axis is one of the central practical questions. Direct receptor-level engagement of the HPG axis is not the principal mechanism, but downstream effects on testosterone, LH/FSH, and prolactin can still occur and warrant baseline and follow-up labs in male users. The practical takeaway is that any male user beginning a course of DSIP should have a baseline hormone panel and a follow-up at 6–8 weeks to detect drift.

Male Physiology Applications

Prostate Health

For prostate health in male users, DSIP is most-effective when paired with comprehensive labs (testosterone total/free, LH, FSH, estradiol sensitive, prolactin, SHBG) at baseline and follow-up. Cycle length 8–12 weeks with re-evaluation.

Testosterone Optimisation

Where male users target testosterone optimisation, DSIP is typically integrated with the broader hormonal protocol — TRT, kisspeptin, gonadorelin, or HCG — rather than used in isolation. The integration approach varies by clinic.

Sleep Quality

Sleep Quality in men responds to DSIP with effect sizes that vary substantially by baseline status — men with documented suboptimal status respond more strongly than those at the upper end of normal. The protocol pattern in clinical use reflects this.

Fat Loss (Male)

For fat loss (male) in male users, DSIP is most-effective when paired with comprehensive labs (testosterone total/free, LH, FSH, estradiol sensitive, prolactin, SHBG) at baseline and follow-up. Cycle length 8–12 weeks with re-evaluation.

Dosing Protocol

Goal	Route	Dose	Cycle
Standard protocol	SubQ	100-500 mcg	8–12 weeks on / 4 weeks off
Conservative starter	SubQ	60-500 mcg	4–6 weeks initial cycle
Men's Health focus	SubQ	100-500 mcg	1x daily before sleep
Maintenance phase	SubQ	70-500 mcg	Ongoing with periodic pauses

Dose timing for DSIP is important relative to food and training given the short half-life. Consistency through the cycle is more important than the precise clock time of individual doses.

Stacking

DSIP stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from men's-health clinicians.

DSIP + Kisspeptin: Activates the KISS1R (GPR54) on GnRH neurons in the hypothalamus, triggering GnRH release. Pairs naturally with DSIP's mechanism in male physiology protocols.
DSIP + Gonadorelin (GnRH): Binds the GnRH receptor on anterior pituitary gonadotrophs in a pulsatile fashion to stimulate LH (and to a lesser extent FSH) release. Pairs naturally with DSIP's mechanism in male physiology protocols.
DSIP + PT-141: Activates MC4R in the hypothalamus and other CNS regions involved in sexual response. Pairs naturally with DSIP's mechanism in male physiology protocols.
DSIP + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with DSIP's mechanism in male physiology protocols.

Safety & Regulatory Status

WADA: Not on prohibited list FDA: Unapproved Research: Preclinical + small human series

Excellent safety record across decades of research use. No reported serious adverse events. Avoid combining with strong CNS depressants.

Lens-specific safety considerations for male physiology use of DSIP: Excellent safety record across decades of research use. No reported serious adverse events. Avoid combining with strong CNS depressants. Additional male physiology monitoring at baseline and 6–8 week follow-up is appropriate.

Clinical Evidence

Primary

DSIP — characterisation and effects on sleep

PMID 6324019

Supporting

DSIP and HPA axis modulation

PMID 20066503

DSIP vs Related Peptides

Compound	Profile	Onset	Best For
DSIP	Neuropeptide (sleep)	~7 min plasma; CNS effects longer	Men's Health
Kisspeptin	Hypothalamic upstream regulator of GnRH	~28 min IV	The upstream master regulator of GnRH neurons — driving the entire HPG axis from above
Gonadorelin (GnRH)	Hypothalamic decapeptide	~2-4 min	The natural decapeptide that drives pituitary release of LH and FSH — used clinically and increasingly as an HCG alternative during testosterone therapy
PT-141	Melanocortin receptor agonist	~2-3 hr	An MC3R/MC4R agonist derived from Melanotan II — FDA-approved as bremelanotide for HSDD in premenopausal women

Frequently Asked Questions

Best time of day to dose for male users?

The pragmatic schedule is morning fasted for compounds engaging the GH axis (preserving the natural overnight pulse), evening for compounds supporting sleep, and PRN for compounds with acute effects (PT-141, etc.). The schedule should fit the user's daily reality more than the textbook ideal.

Will DSIP affect fertility or sperm quality?

Sperm parameters reflect a 70–90 day spermatogenic cycle, so any meaningful effect on sperm count and motility requires at least one full cycle to manifest. DSIP's direct effect on spermatogenesis varies by mechanism. Men actively pursuing fertility should baseline semen analysis before and after cycles to track.

Is DSIP compatible with TRT?

For most men on TRT, DSIP is compatible. The interaction depends on whether the compound engages the same axis (somatotrophic, HPG, melanocortin) as the TRT-paired stack components. Working with a TRT-knowledgeable physician on dose layering avoids the most common pitfalls.

Can I use DSIP during a cut?

Yes, and several compounds in this class are specifically protective of lean mass in caloric deficit. The dose-timing relative to training and the protein intake matter more than the absolute dose. Cardiovascular and metabolic monitoring continues to apply.

Will DSIP affect testosterone or my HPG axis?

DSIP's effect on the HPG axis depends on its primary mechanism. Direct HPG-axis engagement is not the principal mechanism, but indirect effects via inflammation, metabolic status, or hepatic SHBG may produce hormone shifts that warrant baseline and follow-up labs. The standard male monitoring panel applies.

Is DSIP safe during pregnancy or breastfeeding?

DSIP, like most non-approved peptide therapeutics, does not have safety data supporting use during pregnancy or lactation. The default position is contraindication during pregnancy, lactation, and active conception, with discontinuation at least 2–3 cycles before planned conception. Approved indications (where they exist) may have specific guidance — verify with the prescribing physician.

Clinical Protocol

Start a DSIP Protocol

Alukard provides physician-supervised men's health protocols with GMP-certified DSIP and GMP-certified compounds with comprehensive hormone panels.

Get Protocol

Quick Facts

Molecular weight: 848 Da
Sequence length: 9 aa
Half-life: ~7 min plasma; CNS effects longer
WADA: Not on prohibited list
FDA: Unapproved
Research: Preclinical + small human series

Stack Partners

Kisspeptin

Gonadorelin (GnRH)

PT-141

Ipamorelin

CJC-1295 without DAC (Mod GRF 1-29)

Research Note

All male physiology applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for DSIP unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.

Physician-supervised men's health protocols

Start Your Male Physiology Protocol for DSIP

Alukard provides physician-supervised men's health protocols with GMP-certified compounds with comprehensive hormone panels.

Get a Physician Consultation View All Compounds

HIPAA Compliant · GMP Certified · Physician Supervised